Because D6D inhibition does not seem to significantly affect cell proliferation in in vitro models (Figure S7), we suspect that the anti-tumor effects of D6D inhibition may be due to its influence on characteristics of the tumor microenvironment, such as angiogenesis and inflammation. The gene discussed is FADS2; the disease is neoplasm.